LITFULO

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: ad46286fa96fa7ca
Drug Approval Canada Name: LITFULO
Product Name: LITFULO
Status: Marketed
Status Date: 2024-02-13
Original Market Date: 2024-02-13
Din: 02543532
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 84:06.16
Atc Original: L04AF08 RITLECITINIB
Atc Name: l 04 af 08
Aig Number: 0165362001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

RITLECITINIB (RITLECITINIB TOSYLATE)

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ad46286fa96fa7ca

Type

Standard